Jan 18, 2017 14:02 pm UTC| Business
VANCOUVER, British Columbia, Jan. 18, 2017 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) / (FKT:1MG) / (OTC:MGXMF) is pleased to provide additional details from the Company’s recent extraction of lithium from...
Merger Mines Corporation Signs Agreement with Groundhog Mining and Milling, LLC
Jan 18, 2017 14:02 pm UTC| Business
COEUR D’ALENE, Idaho, Jan. 18, 2017 -- Merger Mines Corporation of Coeur d’Alene, Idaho is pleased to announce that it has signed an agreement with Groundhog Mining and Milling, LLC of Dillon, Montana to form a working...
American Airlines Introduces New Basic Economy Fare
Jan 18, 2017 14:01 pm UTC| Business
FORT WORTH, Texas, Jan. 18, 2017 -- American Airlines (Nasdaq:AAL) today announced it will begin selling Basic Economy fares in addition to the wide range of Main Cabin fares currently offered. These no-frills tickets...
American Airlines Introduces New Basic Economy Fare
Jan 18, 2017 14:01 pm UTC| Business
FORT WORTH, Texas, Jan. 18, 2017 -- American Airlines (Nasdaq:AAL) today announced it will begin selling Basic Economy fares in addition to the wide range of Main Cabin fares currently offered. These no-frills tickets...
Immunomedics Announces New Data for IMMU-132 at Investor R&D Day
Jan 18, 2017 14:01 pm UTC| Business
-- IMMU-132 Provides Opportunity for Significant Near-Term Value Creation -- -- Submission for Accelerated Approval Application to FDA for Patients with Metastatic TNBC Remains on Track for mid-2017 -- -- Company...
Immunomedics Announces New Data for IMMU-132 at Investor R&D Day
Jan 18, 2017 14:01 pm UTC| Business
-- IMMU-132 Provides Opportunity for Significant Near-Term Value Creation -- -- Submission for Accelerated Approval Application to FDA for Patients with Metastatic TNBC Remains on Track for mid-2017 -- -- Company...
PharmaCyte Biotech to Hold Shareholder Call
Jan 18, 2017 14:01 pm UTC| Business
LAGUNA HILLS, Calif., Jan. 18, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell...